89bio CEO Rohan Palekar's 2022 pay falls 36% to $3.1M
89bio reports 2022 executive compensation
By ExecPay News
Published: April 24, 2023
89bio reported fiscal year 2022 executive compensation information on April 24, 2023.
In 2022, three 89bio executives received on average a compensation package of $2.1M, a 30% decrease compared to previous year.
Rohan Palekar, Chief Executive Officer, received $3.1M in total, which decreased by 36% compared to 2021. 45% of Palekar's compensation, or $1.4M, was in stock awards. Palekar also received $388K in non-equity incentive plan, $736K in option awards, $588K in salary, as well as $15K in other compensation.
Hank Mansbach, Chief Medical Officer, received a compensation package of $1.5M, which decreased by 22% compared to previous year. 40% of the compensation package, or $609K, was in stock awards.
Quoc Le-Nguyen, Chief Technical Operations Officer and Head of Quality, earned $1.5M in 2022, a 23% decrease compared to previous year.